Skip Navigation
Markets
Pre-Markets
U.S. Markets
Europe Markets
China Markets
Asia Markets
World Markets
Currencies
Prediction Markets
Cryptocurrency
Futures & Commodities
Bonds
Funds & ETFs
Business
Economy
Finance
Health & Science
Media
Real Estate
Energy
Climate
Transportation
Investigations
Industrials
Retail
Wealth
Sports
Life
Small Business
Investing
Personal Finance
Fintech
Financial Advisors
Options Action
ETF Street
Buffett Archive
Earnings
Trader Talk
Tech
Cybersecurity
AI
Enterprise
Internet
Media
Mobile
Social Media
CNBC Disruptor 50
Tech Guide
Politics
White House
Policy
Defense
Congress
Expanding Opportunity
Europe Politics
China Politics
Asia Politics
World Politics
Video
Latest Video
Full Episodes
Livestream
Top Video
Live Audio
Europe TV
Asia TV
CNBC Podcasts
CEO Interviews
Digital Originals
Watchlist
Investing Club
Trust Portfolio
Analysis
Trade Alerts
Meeting Videos
Homestretch
Jim's Columns
Education
Subscribe
PRO
Pro News
Josh Brown
Mike Santoli
Calls of the Day
My Portfolio
Livestream
Full Episodes
Stock Screener
Market Forecast
Options Investing
Chart Investing
Subscribe
Livestream
Menu
Make It
select
USA
INTL
Livestream
Search quotes, news & videos
Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics
Video
Watchlist
Investing Club
PRO
Livestream
Menu
Business News
J.P. Morgan Healthcare Conference
Jim Cramer says don’t trade Apple and Nvidia as money rotates into overlooked stocks ahead of earnings season
Luke Fountain
Fri, Jan 9th 2026
Europe's best-performing blue-chip stock has become a prime takeover target
Elsa Ohlen
Fri, Jan 9th 2026
Why we're trimming after Monday's rout, plus our hopes for Starbucks's earnings
Paulina Likos
Tue, Jan 28th 2025
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Annika Kim Constantino
Mon, Jan 27th 2025
Meta's increased AI spending helps both of our two chipmakers, but one especially
Paulina Likos
Fri, Jan 24th 2025
Morning Meeting
Cramer says buy the most undervalued healthcare stock — even after recent bounce
Tue, Jan 21st 2025
Morning Meeting
Bond yield relief boosts 2 portfolio stocks — plus, Lilly after Tuesday's slide
Wed, Jan 15th 2025
watch now
watch now
VIDEO
05:26
Fast Money
M&A, obesity top of mind for investors at J.P. Morgan Healthcare conference: Portal Innovations CEO
Fri, Jan 10th 2025
J.P. Morgan Healthcare Conference
Vir Biotechnology CEO George Scangos at annual J.P. Morgan Healthcare Conference
Tue, Jan 14th 2020
Health and Science
Novartis strikes deal with UK to provide cholesterol drug to high-risk patients
Mon, Jan 13th 2020
Mad Money
Winners & losers from JP Morgan Healthcare Conference
Tue, Jan 16th 2018
Trending Now
1
Sellers are pulling homes off the market at the fastest pace since 2020
2
Why we're raising our price target on Broadcom despite its post-earnings sell-off
3
Broadcom stock plunges on weak software sales, unchanged AI chip forecast for the year
4
Highly successful people use 5 phrases to disagree with their bosses: You’ll ‘earn their respect and trust,’ says expert
5
Asia-Pacific markets open lower on renewed Middle East tensions
More In J.P. Morgan Healthcare Conference
watch now
watch now
VIDEO
10:52
Mad Money
Cramer reveals the biggest winners and losers from the JP Morgan Healthcare Conference
Tue, Jan 16th 2018
Mad Money
Cramer Remix: Prospect of buybacks should calm fears of a major market decline
Tue, Jan 16th 2018
Mad Money
Cramer reveals the winners and losers from the JP Morgan Healthcare Conference
Tue, Jan 16th 2018
J.P. Morgan Healthcare Conference
Here's what people talked about at JP Morgan's health-care conference
Fri, Jan 12th 2018
Fast Money
Regeneron CEO talks drug pricing and tax reform
Tue, Jan 9th 2018
Closing Bell
Verily's Project Baseline: 'Google Maps for health'
Thu, Jan 31st 2019
watch now
watch now
VIDEO
04:04
Closing Bell
Gilead CEO: We still intend to invest in M&A and our pipeline
Tue, Jan 9th 2018
watch now
watch now
VIDEO
01:56
Power Lunch
Valeant CEO: We took an appropriate response to pricing with recent increase
Tue, Jan 9th 2018
watch now
watch now
VIDEO
07:40
J.P. Morgan Healthcare Conference
Full interview with Amicus CEO John Crowley
Tue, Jan 9th 2018
J.P. Morgan Healthcare Conference
Allergan CEO Saunders on the company's booming Botox business
Tue, Jan 9th 2018
Squawk on the Street
Johnson & Johnson CEO: We should all be acting like Amazon's getting into our business
Tue, Jan 9th 2018
Squawk Box
Illumina CEO: Seeing big growth in genomic testing
Tue, Jan 9th 2018
watch now
watch now
VIDEO
01:32
Squawk Box
JP Morgan Health Care Conference in full swing. Here's what to expect
Tue, Jan 9th 2018
J.P. Morgan Healthcare Conference
Biotech and pharma firms like the US tax law — but not because of their new rates
Mon, Jan 8th 2018
Mad Money
Cramer Remix: Tesla’s stock is up for one simple reason
Mon, Jan 8th 2018
Mad Money
'Best days are still ahead' for top opioid addiction treatment, CEO says
Mon, Jan 8th 2018
J.P. Morgan Healthcare Conference
Merck CEO says more of drug rebates should end up with consumers
Mon, Jan 8th 2018
J.P. Morgan Healthcare Conference
Full interview with Shire CEO Flemming Ørnskov
Mon, Jan 8th 2018
J.P. Morgan Healthcare Conference
BioMarin's chief calls hemophilia treatment results 'extremely encouraging'
Tue, Jan 9th 2018
watch now
watch now
VIDEO
04:26
Closing Bell
Merck CEO: We continue to work with Trump Administration to try and do what's good for patients
Mon, Jan 8th 2018
watch now
watch now
VIDEO
06:16
J.P. Morgan Healthcare Conference
Full interview with MyoKardia CEO Tassos Gianakakos
Tue, Jan 9th 2018
J.P. Morgan Healthcare Conference
Incyte chief discusses company's latest cancer treatments, U.S. tax cuts
Mon, Apr 9th 2018
J.P. Morgan Healthcare Conference
BioMarin CEO on hemophilia treatment success
Mon, Jan 8th 2018
Power Lunch
Editas lower on questions about Crispr efficacy
Mon, Jan 8th 2018
Load More
